Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effectSouichi Shiratori, Atsushi Yasumoto, Junji Tanaka, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemiaAkio Shigematsu, Takeshi Kondo, Satoshi Yamamoto, et al.Antiviral Research|August 30, 2025
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseasesTakaya Ichikawa, Tomokazu Tamura, Naganori Nao, et al.Blood Advances|February 21, 2019
A role for IL-34 in osteolytic disease of multiple myelomaMuhammad Baghdadi, Kozo Ishikawa, Sayaka Nakanishi, et al.International Journal of Hematology|January 21, 2010
Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantationTakeshi Kondo, Atsushi Yasumoto, Kotaro Arita, et al.International Journal of Hematology|March 20, 2026
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in JapanFumiaki Fujii, Masahiro Onozawa, Shota Yoshida, et al.Haematologica|June 13, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study GroupKoh Izumiyama, Tasuku Inao, Hideki Goto, et al.PNAS Nexus|March 31, 2025
Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patientsChisako Iriyama, Takaya Ichikawa, Tomokazu Tamura, et al.Annals of Hematology|November 30, 2024
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AMLToshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, et al.Pageof 4